AMHRII-BINDING COMPOUNDS FOR PREVENTING OR TREATING LUNG CANCERS

The present invention relates to a human AMHRII-binding agent for its use for preventing or treating a lung cancer, and especially a non-small call lung cancer (NSCLC), and even more especially a NSCLC selected in a group comprising epidermoid NSCLC, adenocarcinoma NSCLC, large cells NSCLC and squam...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	NICOLAS André, LAHMAR Mehdi, DEGOVE Stéphane, PROST Jean-françois, MESEURE Didier, DUBREUIL Olivier, BARRET Jean-marc
Format:	Patent
Sprache:	eng ; spa
Schlagworte:	CHEMISTRY HUMAN NECESSITIES HYGIENE INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PHYSICS PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention relates to a human AMHRII-binding agent for its use for preventing or treating a lung cancer, and especially a non-small call lung cancer (NSCLC), and even more especially a NSCLC selected in a group comprising epidermoid NSCLC, adenocarcinoma NSCLC, large cells NSCLC and squamous cell carcinoma NSCLC and neuroendocrine NSCLC. La presente invención se refiere a un agente de unión a AMHRII humano para su uso para prevenir o tratar un cáncer de pulmón, y especialmente un cáncer de pulmón no pequeño (NSCLC), y aún más especialmente un NSCLC seleccionado de un grupo que comprende NSCLC epidermoide, NSCLC de adenocarcinoma, NSCLC de células grandes y NSCLC de carcinoma de células escamosas y NSCLC neuroendocrino.